Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug - Wikidata - awgldk - TriplyDB

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

http://www.wikidata.org/entity/Q35978848

about

Characterization of a monoclonal antibody to L1210 leukaemia.Antibody-dependent cellular cytotoxicity against drug-induced antigens in L5178Y mouse lymphoma Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Combination chemotherapy with folate antagonists.Quantitative analysis and clonal characterization of T-cell receptor β repertoires in patients with advanced non-small cell lung cancer treated with cancer vaccine.Drug induced modulation of immune responses in mice: effects of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) and cyclophosphamide (Cy).In vitro combined effects of a triazene compound and interferon-beta on natural immunity against lymphoblastoid cells: studies at effector and target cell level.Drug-mediated changes in the susceptibility of human lymphoblastoid B cells to NK-mediated cytolysis: studies with a triazene compound.DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system.Cisplatin increases sensitivity of human leukemic blasts to triazene compounds.

P2860

Q36046139-2DC24CE9-C206-4C7B-A5BE-F67E5E14881B Q36046898-341056C2-355B-487F-8C3F-6CD6F6C060E5 Q36306803-ACAD43DD-4527-49BA-8C98-E61DDF6F1B0D Q36466581-3C00158A-2C7C-4ED7-A348-57D74E5F93A6 Q38730989-D2258F6F-E3B3-4082-B19E-BF20853A34E8 Q40004613-004275B5-FBB8-4B05-B665-F2A3D6D2E771 Q40978230-B5D8951C-58A3-4F86-A756-10F699120E72 Q41218599-24321469-33CD-446D-87C5-7DA9D5953C1A Q41432551-94DF6C5B-0E22-46EE-B6F6-3D90E78D3D46 Q41440667-603450A5-AA51-4097-80B6-20185BDBD23E Q44471917-0881823B-1135-43D3-BEBC-5D43D8B8665F Q53756401-1B50E1DF-DB29-4C62-8AC8-8BF8A2B84AC7

P2860

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

http://www.wikidata.org/entity/Q35978848

description

1970 nî lūn-bûn

@nan

1970年の論文

@ja

1970年論文

@yue

1970年論文

@zh-hant

1970年論文

@zh-hk

1970年論文

@zh-mo

1970年論文

@zh-tw

1970年论文

@wuu

1970年论文

@zh

1970年论文

@zh-cn

name

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

@ast

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

@en

type

label

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

@ast

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

@en

prefLabel

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

@ast

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

@en

P1433

Q35978848-BCD0791D-4692-4203-AF00-2F8BF9F90AB4

P1476

Q35978848-5A4E32FD-F85F-4C00-B479-E066F57B0831

P2093

Q35978848-25BD5949-5A66-44C1-BC58-D03C9D393895

Q35978848-4F4301F2-6E87-4BCC-804B-85480B44E218

Q35978848-C8A53A7F-2F30-4573-B709-E3DAF9DEBA88

Q35978848-CD35B95E-266E-4D09-A294-387FBF1D2870

P2860

Q35978848-0AD61425-A4EB-4E07-A3D4-20E0290ABD05

Q35978848-2182D2EA-4780-4A82-B58A-87565FE7EEFA

Q35978848-2E640AAA-0FB6-4124-8170-2E565D2070B5

Q35978848-5CA5A176-7B3F-42DD-8D9D-FBE931FCD410

Q35978848-688CEE46-1EBF-4C85-ADC1-BE00B933BF71

Q35978848-7E45DB7A-E784-4B43-831D-38ED2872E04D

Q35978848-9F7BA5BD-BF48-4F28-9AF1-A46B7D3288F9

P304

Q35978848-94870A04-5110-4DD1-86EE-EB97E5F52C45

P31

Q35978848-8E43192A-47B0-4597-89EC-F5293551E0A8

P356

Q35978848-48597A0E-3600-4DC5-9D5C-F37CE082FA5C

P407

Q35978848-AB06EFF8-ADC4-4B12-B3BA-DFC05B25CAF6

P433

Q35978848-35C018A4-2D48-409F-9614-334D05C70B91

P478

Q35978848-4AC83B82-CB26-4AA1-8DE9-26E1B8AF3F39

P577

Q35978848-A682A38C-0EA2-405B-BBD9-476CAE3FDC45

P5875

Q35978848-BFBBF697-CB86-4B9A-8FD1-0B285B9991C9

P698

Q35978848-452E997C-572E-4B5C-A81D-EAF8BF7BE354

P921

Q35978848-7A55D9D4-11DE-45E1-940C-51FC8D8BADA3

Q35978848-826D74EC-DAEB-46E6-8484-734EC5CA964E

P932

Q35978848-96AB30DF-104C-4CF6-8563-542F4302B6B0

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

@en

P2093

Bonmassar A

http://www.w3.org/2001/XMLSchema#string

Bonmassar E

http://www.w3.org/2001/XMLSchema#string

Goldin A

http://www.w3.org/2001/XMLSchema#string

Vadlamudi S

http://www.w3.org/2001/XMLSchema#string

P2860

ON THE TOPOGRAPHY OF THE GENETIC FINE STRUCTURE

In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate.

Cellular differentiation of the immune system of mice. I. Separate splenic antigen-sensitive units for different types of anti-sheep antibody-forming cells

Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative.

Chemical deletion of histocompatibility antigens--homograft survival of rat skin treated with "Urethan" in vitro.

Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.

PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE.

P304

1089-1095

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.66.4.1089

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

1970-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

17896563

http://www.w3.org/2001/XMLSchema#string

P698

5273445

http://www.w3.org/2001/XMLSchema#string

P921

P932

335790

http://www.w3.org/2001/XMLSchema#string